Kadcyla and Solutions for Reconstitution and Dilution
This article responds to your request for information on Kadcyla® (trastuzumab emtansine) and compatibility with solutions for reconstitution and dilution.
Last updated December 04, 2023
Recommended solutions for reconstitution and dilution
Kadcyla lyophilised powder should be reconstituted with sterile water according to the vial size and volume presented in Table 1.[1] The reconstituted solution should be further diluted with 0.9% NaCl or 0.45% NaCl.[1]
Table 1. Sterile water volume for reconstitution
If Kadcyla was inadvertently reconstituted or diluted with a solution other than as described in the prescribing information, contact your local medical information service.
Precaution against using dextrose 5% solution
Roche recommends against reconstituting or diluting with dextrose (or glucose) 5% solution as it causes aggregation of the protein.[1]
Precaution against admixtures
Kadcyla should not be reconstituted, diluted, or mixed with other drugs.[1]
References
1. Roche Internal Regulatory Report. Accessed 12 July 2023.
Medinfo
Need to contact Roche?
Request Product Information
Request Product Information
Ask us a question and request information about Roche products or services.
Report a potential side effect
Report a potential side effect
If you have experienced potential side effects with a Roche product you can report it here.
Report a potential product defect
Report a potential product defect
If you suspect a potential defect or a Roche product has not met your expectations you can report it here.
Request temperature stability assessment
Request temperature stability assessment
Request an assessment if your product was stored outside the recommended temperature range.
